Lutonix™
![](/Image.php?p=/357/lutonix_1694118428.png)
Lutonix™
The Lutonix™ Drug Coated Balloon PTA Catheter is offered in 0.018 and 0.035 guidewire configurations for the treatment of de novo, restenotic, or in-stent restenotic lesions in the superficial femoral and popliteal arteries. The Lutonix™ DCB delivers a dose of 2 µg/mm2 of paclitaxel and is designed to provide the versatility needed to treat lesions of varying sizes and lengths. It is engineered to enhance femoropopliteal procedures by providing:
A robust size matrix
Extensive indications
![](https://www.renalpharma.com/uploads/_CGSmartImage/1692734508_0_BD_logo-bf73b8bdad3777ee3f5e12bac93257c6.png)